amitriptyline has been researched along with substance p in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carraway, RE; Cochrane, DE; Granier, C; Kitabgi, P; Leeman, E; Singer, EA | 1 |
| Brodin, E; Brodin, K; Ogren, SO | 1 |
| Iwamoto, T; Kohri, H; Noguchi, K; Ohara, M; Sato, S; Senba, E; Yasuda, T | 1 |
| Diaz, J; Lammers, CH; Schwartz, JC; Sokoloff, P | 1 |
| Deuschle, M; Fiebich, BL; Herpfer, I; Heuser, I; Lieb, K; Sander, P | 1 |
| Chen, X; Dong, Z; Li, Z; Liang, J; Liu, R; Wang, X; Yu, S | 1 |
1 trial(s) available for amitriptyline and substance p
| Article | Year |
|---|---|
Substance P in serum and cerebrospinal fluid of depressed patients: no effect of antidepressant treatment.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychometrics; Receptors, Neurokinin-1; Severity of Illness Index; Substance P | 2005 |
5 other study(ies) available for amitriptyline and substance p
| Article | Year |
|---|---|
Parallel secretion of endogenous 5-hydroxytryptamine and histamine from mast cells stimulated by vasoactive peptides and compound 48/80.
Topics: Amitriptyline; Animals; Female; Histamine Release; In Vitro Techniques; Male; Mast Cells; Neurotensin; p-Methoxy-N-methylphenethylamine; Peptides; Rats; Rats, Inbred Strains; Serotonin; Somatostatin; Substance P | 1984 |
Clomipramine and clonazepam increase cholecystokinin levels in rat ventral tegmental area and limbic regions.
Topics: Amitriptyline; Animals; Cholecystokinin; Clomipramine; Clonazepam; Infusion Pumps, Implantable; Limbic System; Male; Nortriptyline; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Substance P; Ventral Tegmental Area | 1994 |
The novel analgesic compound OT-7100 (5-n-butyl-7-(3,4,5-trimethoxybenzoylamino)pyrazolo[1,5-a]pyrimid ine) attenuates mechanical nociceptive responses in animal models of acute and peripheral neuropathic hyperalgesia.
Topics: Amitriptyline; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents, Tricyclic; Clonazepam; Dinoprostone; Disease Models, Animal; Hyperalgesia; Indomethacin; Male; Neuralgia; Pain; Pain Threshold; Peripheral Nerve Injuries; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Pyrimidines; Rats; Rats, Sprague-Dawley; Saccharomyces cerevisiae; Sciatic Nerve; Seminal Vesicles; Sheep; Substance P | 1999 |
Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments.
Topics: Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Desipramine; Dopamine; Dynorphins; Electroshock; Fluoxetine; Gene Expression; Imipramine; Islands of Calleja; Limbic System; Male; Monoamine Oxidase Inhibitors; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger; Substance P; Tranylcypromine | 2000 |
The effects of OB-induced depression on nociceptive behaviors induced by electrical stimulation of the dura mater surrounding the superior sagittal sinus.
Topics: Amitriptyline; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Dura Mater; Electric Stimulation; Male; Migraine Disorders; Olfactory Bulb; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Substance P; Superior Sagittal Sinus | 2011 |